Jakob; Clarissa

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jakob; Clarissa.The latest application filed is for "novel inhibitor compounds of phosphodiesterase type 10a".

Company Profile

0.11.14

Jakob; Clarissa - North Chicago IL
Jakob; Clarissa - Abbott Park IL
Jakob; Clarissa - Grayslake IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitor compounds of phosphodiesterase type 10A Grant 10,308,610 - Geneste , et al.	2019-06-04
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20180222905 - Geneste; Herve ; et al.	2018-08-09
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20180099936 - Geneste; Herve ; et al.	2018-04-12
Inhibitor compounds of phosphodiesterase type 10A Grant 9,938,269 - Geneste , et al. April 10, 2	2018-04-10
Inhibitor compounds of phosphodiesterase type 10A Grant 9,856,220 - Geneste , et al. January 2, 2	2018-01-02
Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors Grant 9,657,034 - Geneste , et al. May 23, 2	2017-05-23
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20160318871 - Geneste; Herve ; et al.	2016-11-03
Inhibitor compounds of phosphodiesterase type 10A Grant 9,475,808 - Geneste , et al. October 25, 2	2016-10-25
Inhibitor compounds of phosphodiesterase type 10A Grant 9,464,085 - Geneste , et al. October 11, 2	2016-10-11
Inhibitor compounds of phosphodiesterase type 10A Grant 9,388,180 - Geneste , et al. July 12, 2	2016-07-12
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20160137668 - GENESTE; Herve ; et al.	2016-05-19
Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A Grant 9,273,068 - Geneste , et al. March 1, 2	2016-03-01
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20160002231 - GENESTE; Herve ; et al.	2016-01-07
Inhibitor compounds of phosphodiesterase type 10A Grant 9,200,005 - Jantos , et al. December 1, 2	2015-12-01
Inhibitor compounds of phosphodiesterase type 10A Grant 9,163,019 - Geneste , et al. October 20, 2	2015-10-20
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20140303153 - GENESTE; Herve ; et al.	2014-10-09
Novel inhibitor compounds of phosphodiesterase type 10A App 20140275069 - JANTOS; Katja ; et al.	2014-09-18
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20140107126 - GENESTE; Herve ; et al.	2014-04-17
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20140051695 - GENESTE; Herve ; et al.	2014-02-20
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20130116233 - Geneste; Herve ; et al.	2013-05-09
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20130116241 - Geneste; Herve ; et al.	2013-05-09
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20130116229 - Geneste; Herve ; et al.	2013-05-09
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20130005705 - Geneste; Herve ; et al.	2013-01-03
Antibodies to Erythropoietin Receptor and Uses Thereof App 20080038265 - Reilly; Edward B. ; et al.	2008-02-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.